Article Details

Xeris Biopharma Holdings Inc.: Why Investors Shouldn't Get Rid Of XERS Stock In 2022

Retrieved on: 2022-12-26 18:01:29

Tags for this article:

Click the tags to see associated articles and topics

Xeris Biopharma Holdings Inc.: Why Investors Shouldn't Get Rid Of XERS Stock In 2022. View article details on HISWAI: https://marketingsentinel.com/2022/12/26/xeris-biopharma-holdings-inc-why-investors-shouldnt-get-rid-of-xers-stock-in-2022/

Excerpt

In the last trading session, 0.38 million shares of the Xeris Biopharma Holdings Inc. (NASDAQ:XERS) were traded, and its beta was 1.39.

Article found on: marketingsentinel.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up